Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H15F2N3S.ClH |
| Molecular Weight | 331.812 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCC1=CNC(=S)N1[C@H]2CCC3=C(F)C=C(F)C=C3C2
InChI
InChIKey=DIPDUAJWNBEVOY-PPHPATTJSA-N
InChI=1S/C14H15F2N3S.ClH/c15-9-3-8-4-10(1-2-12(8)13(16)5-9)19-11(6-17)7-18-14(19)20;/h3,5,7,10H,1-2,4,6,17H2,(H,18,20);1H/t10-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H15F2N3S |
| Molecular Weight | 295.351 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9283721Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25602710
https://www.ncbi.nlm.nih.gov/pubmed/24983834
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9283721
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25602710
https://www.ncbi.nlm.nih.gov/pubmed/24983834
Nepicastat (SYN-117) is a potent and selective inhibitor of dopamine-β-hydroxylase. This compound in Phase 2 of clinical trial for the treatment cocaine addiction and posttraumatic stress disorder.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23303068
Curator's Comment: Nepicastat is direct, competitive inhibitor of DBH that does not chelate copper, can cross the blood–brain barrier
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3102 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9283721 |
9.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. | 2010-11 |
|
| Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. | 2008-06 |
|
| Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase. | 2006-02-09 |
|
| Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. | 1997-08 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: https://clinicaltrials.gov/ct2/show/NCT01704196?term=NEPICASTAT&rank=3
Post Traumatic Stress Disorder: 120 mg/day
Cocaine Dependence: Nepicastat 120 mg and 100 mg riboflavin (once per day) for 11 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9283721
Nepicastat produced concentration-dependent inhibition of bovine and human dopamine-beta-hydroxylase activity. The calculated IC50s for nepicastat were 8.5+0.8 nM and 9.0+0.8 nM for the bovine and human enzyme, respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:25:51 GMT 2025
by
admin
on
Mon Mar 31 21:25:51 GMT 2025
|
| Record UNII |
3WK068D17I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055542
Created by
admin on Mon Mar 31 21:25:51 GMT 2025 , Edited by admin on Mon Mar 31 21:25:51 GMT 2025
|
PRIMARY | |||
|
9840545
Created by
admin on Mon Mar 31 21:25:51 GMT 2025 , Edited by admin on Mon Mar 31 21:25:51 GMT 2025
|
PRIMARY | |||
|
DTXSID00168811
Created by
admin on Mon Mar 31 21:25:51 GMT 2025 , Edited by admin on Mon Mar 31 21:25:51 GMT 2025
|
PRIMARY | |||
|
3WK068D17I
Created by
admin on Mon Mar 31 21:25:51 GMT 2025 , Edited by admin on Mon Mar 31 21:25:51 GMT 2025
|
PRIMARY | |||
|
170151-24-3
Created by
admin on Mon Mar 31 21:25:51 GMT 2025 , Edited by admin on Mon Mar 31 21:25:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|